{"id": "1369249343748907009", "creation": 1615289457.0, "user_id": "621185967", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 1, "like_count": 2, "quote_count": 0}}, "quoted": "1369225254099419140", "text": "\u201c#Russia's Sputnik V #vaccine against #COVID19 could be produced in Europe for the first time after a commercial deal to produce it in #Italy was signed by the Moscow-based RDIF sovereign wealth fund and #Swiss-based #pharmaceutical company @Adienne.\u201d #procurement https://t.co/wEcpx5m8Vy", "first_save": 1634559108.199414, "hashtags": ["#RUSSIA", "#VACCINE", "#COVID19", "#ITALY", "#SWISS", "#PHARMACEUTICAL", "#PROCUREMENT"]}